Skip to main content
logo
10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
22.62
-0.52 (-2.25%)
Mar 3, 2026, 4:00 PM EST - Market closed

10x Genomics Revenue

In the year 2025, 10x Genomics had annual revenue of $642.82M with 5.25% growth. 10x Genomics had revenue of $166.03M in the quarter ending December 31, 2025, with 0.61% growth.

Revenue (ttm)
$642.82M
Revenue Growth
+5.25%
P/S Ratio
4.50
Revenue / Employee
$545,690
Employees
1,178
Market Cap
2.89B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025642.82M32.04M5.25%
Dec 31, 2024610.79M-7.94M-1.28%
Dec 31, 2023618.73M102.32M19.81%
Dec 31, 2022516.41M25.92M5.28%
Dec 31, 2021490.49M191.65M64.13%
Dec 31, 2020298.85M52.95M21.53%
Dec 31, 2019245.89M99.58M68.06%
Dec 31, 2018146.31M75.23M105.83%
Dec 31, 201771.09M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BrightSpring Health Services12.91B
Teladoc Health2.53B
Privia Health Group2.12B
HealthEquity1.29B
Tempus AI1.27B
Omnicell1.18B
Waystar Holding1.10B
Doximity637.78M
Revenue Rankings

TXG News

More News